menu
    • menu

    Company profile for BlueWind Medical

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BlueWind Medical is an innovative medical device company that aims to transform neuromodulation therapy. Founded in 2010 by the Rainbow Medical Group, BlueWind Medical has grown to an established company with diverse, creative and committed employees. BlueWind Medical has successfully completed or is nearing completion of several clinical studies with excellent results and is focused on bringing this breakthrough RENOVA iSt...
    BlueWind Medical is an innovative medical device company that aims to transform neuromodulation therapy. Founded in 2010 by the Rainbow Medical Group, BlueWind Medical has grown to an established company with diverse, creative and committed employees. BlueWind Medical has successfully completed or is nearing completion of several clinical studies with excellent results and is focused on bringing this breakthrough RENOVA iStim™ neuromodulation device for the treatment of Overactive Bladder to the market.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BlueWind MedicalUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1389 Center Drive, Suite 200 Park City, UT 84098
    Telephone
    Telephone
    +972 (0)74 721 8900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://bluewindmedical.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bluewind-medical/?originalSubdomain=il
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Three-Year Data Validate Revi System for Urgency Incontinence
    Three-Year Data Validate Revi System for Urgency Incontinence

    27 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260227984763/en/Three-Year-Data-Reinforce-Revi-System-as-the-Most-Clinically-Validated-Implantable-Tibial-Neuromodulation-Therapy-for-Urgency-Urinary-Incontinence

    BUSINESSWIRE
    27 Feb 2026
    Share Share
    Bluewind Medical Gets FDA Clearance For Enhanced Revi Wearable
    Bluewind Medical Gets FDA Clearance For Enhanced Revi Wearable

    16 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251216057440/en/BlueWind-Medical-Receives-FDA-510k-Clearance-for-Enhanced-Revi-Wearable-Supporting-Long-Term-Treatment-of-Urgency-Urinary-Incontinence

    BUSINESSWIRE
    16 Dec 2025
    Share Share
    Revi® System Shows 24-Month Benefit in Urinary Incontinence
    Revi® System Shows 24-Month Benefit in Urinary Incontinence

    29 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250429154447/en/Revi-System-Demonstrates-Significant-and-Sustained-Quality-of-Life-Benefits-Across-All-Domains-for-the-Majority-of-Patients-with-Urgency-Urinary-Incontinence-at-24-Months

    BUSINESSWIRE
    29 Apr 2025
    Share Share
    Revi® Therapy Data Shows Efficacy In Urgency Urinary Incontinence
    Revi® Therapy Data Shows Efficacy In Urgency Urinary Incontinence

    24 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241024044110/en

    BUSINESSWIRE
    24 Oct 2024
    Share Share
    AUA/SUFU OAB Guideline Allows Earlier Revi™ System Access
    AUA/SUFU OAB Guideline Allows Earlier Revi™ System Access

    29 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/auasufu-guideline-on-the-treatment-of-overactive-bladder-allows-access-to-revitm-system-earlier-in-treatment-journey-302130125.html

    PR NEWSWIRE
    29 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search